Cita APA (7a ed.)

Cen, O., Kannan, K., Sappal, J. H., Yu, J., Zhang, M., Arikan, M., . . . Longnecker, R. (2018). Spleen Tyrosine Kinase Inhibitor TAK-659 Prevents Splenomegaly and Tumor Development in a Murine Model of Epstein-Barr Virus-Associated Lymphoma. American Society for Microbiology.

Cita Chicago Style (17a ed.)

Cen, Osman, et al. Spleen Tyrosine Kinase Inhibitor TAK-659 Prevents Splenomegaly and Tumor Development in a Murine Model of Epstein-Barr Virus-Associated Lymphoma. American Society for Microbiology, 2018.

Cita MLA (8a ed.)

Cen, Osman, et al. Spleen Tyrosine Kinase Inhibitor TAK-659 Prevents Splenomegaly and Tumor Development in a Murine Model of Epstein-Barr Virus-Associated Lymphoma. American Society for Microbiology, 2018.